Revenue rose 5% to $272 million, with system-wide outpatientRevenueup 7.7% andVolumeup 4.9%, the strongest of 2026. Advanced modality mix reached a record. Adjusted EBITDA was $62.6 million, a 23.0% margin.GAAPearnings were $0.07 per share, andNet Incomewas $7.2 million versus a $3.5 million loss a …
MaxCyte agreed to acquire AkronBio from Arcline for $151.8 million in total: $105 million in cash, about $26.8 million in stock and $20 million of guaranteed deferred payments, split evenly between 2028 and 2029. Pro forma 2026 revenue is expected to exceed $60 million, …
Adjusted OIBDA was $3.3 million, including a $700,000 contribution from Captivate, versus $10.2 million a year ago. Management cited two factors. Attendance arrived late in the quarter, after peak advertiser demand, and advertiser budgets shifted toward the FIFA World Cup, which cut cinema commitments …
Net loss was about $4.2 million, helped by a $13 million non-cash gain tied to warrants. SPAC warrants have now been eliminated, simplifying the capital structure. Management gave no financial guidance.
Net revenue fell 2% to $145 million, better than the roughly 5% decline the company had guided and a sharp improvement from the 25% decline in the second quarter. Revenue topped the $140.5 million estimate. Adjusted EPS was $0.37 versus $0.30 expected and $0.40 …
Net sales rose 17.8% at constant currency, 17.2% reported, to CHF 931.4 million. Wholesale grew 13.2% to CHF 538.2 million, and DTC grew 24.8% to CHF 393.3 million, or 42.2% of sales, though DTC growth fell short of the roughly 30% guided. Asia-Pacific grew …
Adjusted EBITDA rose to $6.3 million from $5.1 million, lifting the margin to about 29% from about 20%.GAAPNet Incomewas $1.2 million, or $0.06 per share, and non-GAAP net income was $3.8 million, or $0.20 per diluted share. Expenses fell $5.1 million to $18.9 million …
Premiums grew 72%, andRevenuerose to $53.9 million.Net Incomerose 32% to $11.5 million despite $2.8 million of non-recurring IPO andDebtextinguishment costs. Adjusted EBITDA rose 65% to $25.1 million, and theMarginexpanded to 46.6% from 44.7%.
Gross margin was 44% versus 29% in the second quarter. The operating loss was $13.4 million, and theGAAPnet loss was $12 million, or $0.25 per share.
The combined ratio rose to 91.5% from 79.0%, including 14.8 points of catastrophe and large losses tied to Black Sea and Middle East marine conflicts, worth $115.9 million, and 0.6 points of adverse prior-year development in political risk, violence and terror.